Vaccinations | Dominik Mayer – Products, Asia, Productivity

FDA Approval  

In an op-ed for the Los Angeles Times, Dr. Anita Sircar writes about a severely ill COVID patient she treated. The man had not gotten a vaccination. He wanted to wait for full FDA approval to not be “the government’s guinea pig”.

“Well,” I said, “I am going to treat you with remdesivir, which only recently received FDA approval.” I explained that it had been under an EUA for most of last year and had not been studied or administered as widely as COVID-19 vaccines. That more than 353 million doses of COVID-19 vaccine had been administered in the U.S. along with more than 4.7 billion doses worldwide without any overwhelming, catastrophic side effects. “Not nearly as many doses of remdesivir have been given or studied in people and its long-term side effects are still unknown,” I said. “Do you still want me to give it to you?”

Check the article to see how the story continues.

The Source Code of a Coronavirus Vaccine  

Bert Hubert dives into the source code of the BioNTech/Pfizer SARS-CoV-2 vaccine:

The code of the vaccine starts with the following two nucleotides:


This can be compared very much to every DOS and Windows executable starting with MZ, or UNIX scripts starting with #!. In both life and operating systems, these two characters are not executed in any way. But they have to be there because otherwise nothing happens.

It’s absolutely fascinating how we’re just a combination of myriads of little biological computers.


Finally, the last vaccination. Against Japanese Encephalitis, at the Munich Tropical Institute. The doctor asked me to cough. She said it would suppress the pain stimulus. Never heard of that before.


According to the pharmacy, the vaccine against Japanese Encephalitis is no longer available. The company is doing more research…


The first of eight appointments at different doctors brought me two vaccinations and the prospect of a good deal more in a biweekly cycle. After that, I’ll resist everything. ;-)